Page 79 - AN-2-1

Advanced Neurology Alpha-synuclein, depression and neurodegeneration

https://doi.org/10.1016/j.biopsych.2021.11.025 Diagnosis and treatment. Depress Res Treat, 2011: 893905.
91. Dalle E, Mabandla MV, 2018, Early life stress, depression https://doi.org/10.1155/2011/893905
and Parkinson’s disease: A new approach. Mol Brain, 11: 18.
102. Chen CY, Hung HJ, Chang KH, et al., 2017, Long-term
https://doi.org/10.1186/s13041-018-0356-9 exposure to air pollution and the incidence of Parkinson’s
disease: A nested case-control study. PLoS One, 12, e0182834.
92. Dolotov OV, Inozemtseva LS, Myasoedov NF, et al., 2022,
Stress-induced depression and Alzheimer’s disease: Focus https://doi.org/10.1371/journal.pone.0182834
on astrocytes. Int J Mol Sci, 23: 4999.
103. Guo P, Gong W, Li Y, et al., 2022, Pinpointing novel risk loci
https://doi.org/10.3390/ijms23094999 for Lewy body dementia and the shared genetic etiology
with Alzheimer’s disease and Parkinson’s disease: A large-
93. Calderon-Garciduenas L, Ayala A, 2022, Air pollution,
ultrafine particles, and your brain: Are combustion scale multi-trait association analysis. BMC Med, 20: 214.
nanoparticle emissions and engineered nanoparticles https://doi.org/10.1186/s12916-022-02404-2
causing preventable fatal neurodegenerative diseases and 104. Khan SS, LaCroix M, Boyle G, et al., 2018, Bidirectional
common neuropsychiatric outcomes? Environ Sci Technol, modulation of Alzheimer phenotype by alpha-synuclein in
56: 6847–6856.
mice and primary neurons. Acta Neuropathol, 136: 589–605.
https://doi.org/10.1021/acs.est.1c04706
https://doi.org/10.1007/s00401-018-1886-z
94. Jacobs BM, Belete D, Bestwick J, et al., 2020, Parkinson’s 105. Monge-Garcia V, Garcia-Ayllon MS, Saez-Valero J, et al.,
disease determinants, prediction and gene-environment 2021, Relation between alpha-synuclein and core CSF
interactions in the UK Biobank. J Neurol Neurosurg biomarkers of Alzheimer’s disease. Medicina, 57: 954.
Psychiatry, 91: 1046–1054.
https://doi.org/10.3390/medicina57090954
https://doi.org/10.1136/jnnp-2020-324472
106. Eisenberg DT, Hayes MG, 2011, Testing the null hypothesis:
95. Akiskal HS, 1994, Dysthymia: Clinical and external validity. Comments on ‘Culture-gene coevolution of individualism-
Acta Psychiatr Scand Suppl, 383: 19–23.
collectivism and the serotonin transporter gene’. Proc Biol
https://doi.org/10.1111/j.1600-0447.1994.tb05879.x Sci, 278: 329–332.
96. Brunello N, Akiskal H, Boyer P, et al., 1999, Dysthymia: https://doi.org/10.1098/rspb.2010.0714
Clinical picture, extent of overlap with chronic fatigue 107. Lee PC, Raaschou-Nielsen O, Lill CM, et al., 2016,
syndrome, neuropharmacological considerations, and new Gene-environment interactions linking air pollution
therapeutic vistas. J Affect Disord, 52: 275–290.
and inflammation in Parkinson’s disease. Environ Res,
https://doi.org/10.1016/s0165-0327(98)00163-3 151: 713–720.
97. Reijnders JS, Ehrt U, Weber WE, et al., 2008, A systematic https://doi.org/10.1016/j.envres.2016.09.006
review of prevalence studies of depression in Parkinson’s 108. Borrageiro G, Haylett W, Seedat S, et al., 2018, A review of
disease. Mov Disord, 23: 183–189.
genome-wide transcriptomics studies in Parkinson’s disease.
https://doi.org/10.1002/mds.21803 Eur J Neurosci, 47: 1–16.
98. Migliorelli R, Teson A, Sabe L, et al., 1995, Prevalence and https://doi.org/10.1111/ejn.13760
correlates of dysthymia and major depression among patients 109. Paul KC, Kusters C, Furlong M, et al., 2022, Immune system
with Alzheimer’s disease. Am J Psychiatry, 152: 37–44.
disruptions implicated in whole blood epigenome-wide
https://doi.org/10.1176/ajp.152.1.37 association study of depression among Parkinson’s disease
patients. Brain Behav Immun Health, 26: 100530.
99. Kazmi H, Walker Z, Booij J, et al., 2021, Late onset
depression: Dopaminergic deficit and clinical features of https://doi.org/10.1016/j.bbih.2022.100530
prodromal Parkinson’s disease: A cross-sectional study. 110. Tirozzi A, Quiccione MS, Cerletti C, et al., 2023, A multi-
J Neurol Neurosurg Psychiatry, 92: 158–164.
trait association analysis of brain disorders and platelet traits
https://doi.org/10.1136/jnnp-2020-324266 identifies novel susceptibility loci for major depression,
Alzheimer’s and Parkinson’s disease. Cells, 12: 245.
100. Lehto SM, Tolmunen T, Kuikka J, et al., 2008, Midbrain
serotonin and striatum dopamine transporter binding in https://doi.org/10.3390/cells12020245
double depression: A one-year follow-up study. Neurosci 111. Vanni S, Baldeschi AC, Zattoni M, et al., 2020, Brain aging:
Lett, 441: 291–295.
A Ianus-faced player between health and neurodegeneration.
https://doi.org/10.1016/j.neulet.2008.06.042 J Neurosci Res, 98: 299–311.
101. Ishizaki J, Mimura M, 2011, Dysthymia and apathy: https://doi.org/10.1002/jnr.24379

Volume 2 Issue 1 (2023) 14 https://doi.org/10.36922/an.326